186 related articles for article (PubMed ID: 26761584)
1. Surgery in patients with von Willebrand disease.
Zulfikar B; Koc B; Ak G; Dikici F; Karaman İ; Atalar AC; Bezgal F
Blood Coagul Fibrinolysis; 2016 Oct; 27(7):812-816. PubMed ID: 26761584
[TBL] [Abstract][Full Text] [Related]
2. von Willebrand factor/factor VIII concentrate (Humate-P) for management of elective surgery in adults and children with von Willebrand disease.
Gill JC; Shapiro A; Valentino LA; Bernstein J; Friedman C; Nichols WL; Manco-Johnson M
Haemophilia; 2011 Nov; 17(6):895-905. PubMed ID: 21535320
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of a new generation von Willebrand factor/factor VIII concentrate (Wilate®) in the management of perioperative haemostasis in von Willebrand disease patients undergoing surgery.
Windyga J; von Depka-Prondzinski M;
Thromb Haemost; 2011 Jun; 105(6):1072-9. PubMed ID: 21437358
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of a VWF/FVIII concentrate (wilate
Srivastava A; Serban M; Werner S; Schwartz BA; Kessler CM;
Haemophilia; 2017 Mar; 23(2):264-272. PubMed ID: 28026130
[TBL] [Abstract][Full Text] [Related]
5. Orthopaedic surgery in patients with von Willebrand disease.
Siboni SM; Biguzzi E; Solimeno LP; Pasta G; Mistretta C; Mannucci PM; Peyvandi F
Haemophilia; 2014 Jan; 20(1):133-40. PubMed ID: 23992395
[TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy in bleeding and surgery in von Willebrand patients treated with Fanhdi a highly purified, doubly inactivated FVIII/VWF concentrate.
Hernandez-Navarro F; Quintana M; Jimenez-Yuste V; Alvarez MT; Fernandez-Morata R
Haemophilia; 2008 Sep; 14(5):963-7. PubMed ID: 18624696
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy and safety of the factor VIII/von Willebrand factor concentrate BIOSTATE in patients with von Willebrand's disease: a prospective multi-centre study.
Dunkley S; Baker RI; Pidcock M; Price J; Seldon M; Smith M; Street A; Maher D; Barrese G; Stone C; Lloyd J
Haemophilia; 2010 Jul; 16(4):615-24. PubMed ID: 20331755
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of a high purity, double virus inactivated factor VIII/von Willebrand factor concentrate (Biostate) in patients with von Willebrand disorder requiring invasive or surgical procedures.
Shortt J; Dunkley S; Rickard K; Baker R; Street A
Haemophilia; 2007 Mar; 13(2):144-8. PubMed ID: 17286766
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of factor VIII/von Willebrand's factor concentrate (Haemate-P) in preventing bleeding during surgery or invasive procedures in patients with von Willebrand disease.
Franchini M; Rossetti G; Tagliaferri A; Pattacini C; Pozzoli D; Lippi G; Manzato F; Bertuzzo D; Gandini G
Haematologica; 2003 Nov; 88(11):1279-83. PubMed ID: 14607757
[TBL] [Abstract][Full Text] [Related]
10. Clinical use of Haemate® P in von Willebrand disease: a 25-year retrospective observational study.
Miesbach W; Krekeler S; Wolf Z; Seifried E
Thromb Res; 2015 Mar; 135(3):479-84. PubMed ID: 25595881
[TBL] [Abstract][Full Text] [Related]
11. Optimising local therapy during oral surgery in patients with von Willebrand disease: effective results from a retrospective analysis of 63 cases.
Federici AB; Sacco R; Stabile F; Carpenedo M; Zingaro E; Mannucci PM
Haemophilia; 2000 Mar; 6(2):71-7. PubMed ID: 10781191
[TBL] [Abstract][Full Text] [Related]
12. Perioperative hemostasis management in patients with von Willebrand disease: an institutional experience.
Toenges R; Miesbach W; Ludwig K; Krammer-Steiner B
Blood Coagul Fibrinolysis; 2024 Mar; 35(2):49-55. PubMed ID: 38179696
[TBL] [Abstract][Full Text] [Related]
13. Von Willebrand disease - the 'Dos' and 'Don'ts' in surgery.
Miesbach W; Berntorp E
Eur J Haematol; 2017 Feb; 98(2):121-127. PubMed ID: 27622750
[TBL] [Abstract][Full Text] [Related]
14. Practical aspects of DDAVP use in patients with von Willebrand Disease undergoing invasive procedures: a European survey.
Windyga J; Dolan G; Altisent C; Katsarou O; López Fernández MF; Zülfikar B;
Haemophilia; 2016 Jan; 22(1):110-20. PubMed ID: 26207933
[TBL] [Abstract][Full Text] [Related]
15. A perspective on the use of FVIII concentrates and cryoprecipitate prophylactically in surgery or therapeutically in severe bleeds in patients with von Willebrand disease unresponsive to DDAVP: results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH.
Foster PA
Thromb Haemost; 1995 Nov; 74(5):1370-8. PubMed ID: 8607125
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of Wilate in paediatric VWD patients under 6 years of age - results of a prospective multicentre clinical study including recovery information.
Nowak-Göttl U; Krümpel A; Russo A; Jansen M
Haemophilia; 2013 Nov; 19(6):887-92. PubMed ID: 23919249
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of a von Willebrand factor/factor VIII concentrate (Wilate®): a single centre experience.
Batty P; Chen YH; Bowles L; Hart DP; Platton S; Pasi KJ
Haemophilia; 2014 Nov; 20(6):846-53. PubMed ID: 25102895
[TBL] [Abstract][Full Text] [Related]
18. Outcomes in Patients With Hemophilia and von Willebrand Disease Undergoing Invasive or Surgical Procedures.
Chapin J; Bamme J; Hsu F; Christos P; DeSancho M
Clin Appl Thromb Hemost; 2017 Mar; 23(2):148-154. PubMed ID: 27418638
[TBL] [Abstract][Full Text] [Related]
19. Wilate use in 47 children with von Willebrand disease: the North London paediatric haemophilia network experience.
Khair K; Batty P; Riat R; Bowles L; Burgess C; Chen YH; Hart D; Platton S; Pasi J; Liesner R
Haemophilia; 2015 Jan; 21(1):e44-50. PubMed ID: 25112927
[TBL] [Abstract][Full Text] [Related]
20. Haemostatic management of intraoral bleeding in patients with von Willebrand disease.
Morimoto Y; Yoshioka A; Sugimoto M; Imai Y; Kirita T
Oral Dis; 2005 Jul; 11(4):243-8. PubMed ID: 15984956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
